Gilead Sciences Q3 2026 earnings preview
FROM THE WIRE · SEEKINGALPHA.COM
[Maker Of Coronavirus Trial Drug Remdesivir, Gilead Sciences. Inc., Reports Positive Data Coming From Trials] Justin Sullivan/Getty Images News Gilead Sciences (GILD [https://seekingalpha.com/symbol/GILD]) is scheduled to report third-quarter earnings on Thursday, October 29…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralA large pharma's earnings are expected to decline, relevant for the stock but without a clear surprise signal.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Gilead will report third-quarter results on Thursday, October 29, after market close.
- 02Consensus EPS is $2.19, down 11.3% from a year earlier.
- 03Revenue is projected at $7.8 billion, up 0.4%.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets